Press release
Radiopharmaceuticals Market to Reach USD 13.78 Billion by 2036, Driven by Precision Oncology and Nuclear Medicine Growth
Radiopharmaceuticals Market projected to reach USD 13.78 Billion by 2036, driven by precision oncology.
PUNE, India - Quintile Reports today announced the publication of its latest market intelligence study, "Radiopharmaceuticals Market (2026-2036)," providing comprehensive analysis of market size, growth trends, competitive landscape, emerging technologies, and future opportunities across the global nuclear medicine industry. According to the report, the global Radiopharmaceuticals Market is valued at USD 7.82 billion in 2026 and is projected to reach USD 13.78 billion by 2036, expanding at a CAGR of 5.48% during the forecast period.
Radiopharmaceuticals are transforming modern healthcare by enabling clinicians to diagnose, monitor, and treat complex diseases with exceptional precision. Widely used in Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), these radioactive compounds play a critical role in oncology, cardiology, neurology, and other specialized therapeutic areas. Growing investments in molecular imaging, theranostics, and personalized medicine continue to accelerate the adoption of advanced nuclear medicine technologies across developed and emerging healthcare markets.
Radiopharmaceuticals Market Report:
https://www.quintilereports.com/industry-report/1298-radiopharmaceuticals-market/
According to Quintile Reports, the increasing global burden of cancer remains the strongest growth driver for the industry. Rising demand for early disease detection, personalized treatment planning, and targeted radioligand therapies is encouraging healthcare providers to expand PET and SPECT imaging capabilities. Continuous innovation in isotopes such as Lutetium-177, Gallium-68, Actinium-225, and Radium-223 is also creating new opportunities for precision oncology and next-generation targeted therapies.
"Radiopharmaceuticals are becoming one of the fastest-evolving segments within precision medicine as healthcare providers increasingly adopt molecular imaging and targeted radionuclide therapies," said a Healthcare Research Analyst at Quintile Reports. "Continued innovation in theranostics and isotope production technologies is expected to create significant long-term opportunities across the global healthcare ecosystem."
The report further highlights that expanding nuclear medicine infrastructure, increasing investments in cyclotrons and radiopharmacy facilities, and improved isotope production capabilities are strengthening the global supply chain. At the same time, regulatory support for innovative radiopharmaceuticals and growing clinical adoption of theranostics are expected to unlock significant long-term growth opportunities for manufacturers, healthcare providers, and research organizations.
The study provides detailed segmentation by product type, application, end user, technology, and region. Diagnostic radiopharmaceuticals continue to account for a significant share of industry revenue, while therapeutic radiopharmaceuticals are witnessing rapid growth due to expanding approvals for targeted cancer treatments. Oncology remains the leading application segment, followed by cardiology, neurology, gastroenterology, nephrology, endocrinology, pulmonology, musculoskeletal disorders, and other chronic disease applications.
From a regional perspective, North America continues to lead the global market, supported by advanced healthcare infrastructure, favorable reimbursement systems, established nuclear medicine networks, and widespread adoption of PET and SPECT imaging. Meanwhile, East Asia is projected to record the fastest growth through 2036, driven by rapid healthcare modernization, expanding oncology care, and increasing investments in advanced diagnostic imaging technologies. India and ASEAN countries are also expected to witness steady growth as governments continue strengthening healthcare infrastructure and expanding access to nuclear medicine services.
Despite favorable market conditions, the report identifies several industry challenges, including limited isotope production capacity, short radioisotope half-lives, complex transportation requirements, stringent regulatory compliance, and high infrastructure investment costs. However, ongoing advancements in isotope manufacturing, targeted alpha and beta therapies, and precision medicine are expected to offset many of these challenges over the coming decade.
The competitive landscape remains dynamic, with companies focusing on isotope production capacity, strategic collaborations, regulatory compliance, portfolio diversification, and innovation in radioligand therapies. Leading companies profiled in the report include Novartis, GE HealthCare, Cardinal Health, Curium Pharma, Bayer, Lantheus Holdings, Bracco Imaging, Jubilant Pharmova, Telix Pharmaceuticals, Eckert & Ziegler, Siemens Healthineers, PharmaLogic Holdings, NorthStar Medical Radioisotopes, ITM Isotope Technologies Munich, and IBA Radiopharma Solutions.
The research combines extensive primary interviews with nuclear medicine physicians, radiopharmacists, hospital procurement specialists, isotope manufacturers, and industry experts with comprehensive secondary research to deliver reliable market forecasts, competitive benchmarking, technology analysis, and strategic business intelligence for industry stakeholders.
For More Information
Request a PDF Sample Report:
https://www.quintilereports.com/request-sample/1298-radiopharmaceuticals-market/
Request a Discount:
https://www.quintilereports.com/request-discount/1298-radiopharmaceuticals-market/
Enquiry Before Purchase:
https://www.quintilereports.com/request-enquiry/1298-radiopharmaceuticals-market/
As demand for precision diagnostics, personalized medicine, and targeted cancer therapies continues to grow worldwide, the radiopharmaceuticals market is expected to remain one of the most strategically important segments within the global healthcare industry over the next decade.
About Quintile Reports
Quintile Reports is a global market research and consulting company specializing in syndicated market research, custom research studies, competitive intelligence, and strategic consulting services across healthcare, pharmaceuticals, biotechnology, medical devices, information technology, chemicals, manufacturing, energy, food & beverages, and numerous other industries. Combining rigorous primary research with advanced analytical methodologies, the company delivers actionable insights that help organizations identify emerging opportunities, evaluate competitive landscapes, optimize investment decisions, and develop long-term growth strategies.
Press Contact
Phone (India & APAC): +91-626-560-6898
HOD: +91-866-833-9034
Email: sales@quintilereports.com
Website: https://www.quintilereports.com/
Quintile Reports
112/1/2, Pyramid Axis,
Behind Croma Showroom,
Veerbhadra Nagar, Baner,
Pune, Maharashtra 411045
India
Phone (India & APAC): +91-626-560-6898
HOD: +91-866-833-9034
Email: sales@quintilereports.com
Website: https://www.quintilereports.com
About Quintile Reports
Quintile Reports is a leading global market research and consulting firm delivering syndicated research, custom research, competitive intelligence, and strategic advisory services across healthcare, pharmaceuticals, biotechnology, information technology, industrial manufacturing, chemicals, energy, automotive, food & beverages, and other high-growth industries. The company combines primary research, industry expertise, and advanced forecasting methodologies to provide actionable insights for business leaders worldwide.
Media Contact:
Quintile Reports
Email: sales@quintilereports.com
Website: https://www.quintilereports.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceuticals Market to Reach USD 13.78 Billion by 2036, Driven by Precision Oncology and Nuclear Medicine Growth here
News-ID: 4563657 • Views: …
More Releases from Quintile Insights
Fire Safety Equipment Market to Reach USD 134.62 Billion by 2035 as Smart Detect …
The Global Fire Safety Equipment Market is poised for substantial long-term expansion, projected to grow from USD 60.32 billion in 2025 to USD 134.62 billion by 2035, registering a robust CAGR of 9.48% during the forecast period from 2026 to 2035. This significant market growth is being fueled by stricter fire safety regulations, rapid urbanization, increased construction of commercial and industrial infrastructure, rising awareness of fire prevention, and the accelerating…
Drone Services Market to Reach USD 34.18 Billion by 2035, Driven by AI-Powered A …
Global Drone Services Market to Reach USD 34.18 Billion by 2035, Driven by AI-Powered Aerial Data, Logistics Innovation, and Industrial Automation
The global Drone Services Market is experiencing significant momentum as industries increasingly adopt unmanned aerial vehicle (UAV)-based solutions to enhance efficiency, safety, and data-driven decision-making. According to recent research by Quintile Reports, the market was valued at USD 10.18 billion in 2025 and is projected to reach USD 34.18 billion…
Industrial refrigeration systems market was valued at USD 20.39 Billion in 2022
Leicester, United Kingdom: The global industrial refrigeration systems market was valued at USD 20.39 Billion in 2022 and it is predicted to rise at a compound annual growth rate (CAGR) of 4.75 % from 2023 to 2032. The use of packaged, processed foods and beverages along with the requirement to stop spoiling are driving up demand for industrial refrigeration systems on a global scale. Global warming worries have compelled businesses…
Dermal fillers market is expected to reach USD 9.45 billion by 2030; expanding a …
Leicester UK, October 2022- The global dermal fillers market was valued at USD 4.98 billion in 2021 and it is the need for minimally invasive aesthetic procedures, particularly in developed nations, is a major factor in the market's growth. The global dermal fillers market is expected to grow at a CAGR of 7.44% during the forecast period to reach USD 9.45 billion by 2030. High patient satisfaction from product development…
More Releases for Radiopharma
Nuclear Pharmacy Market Future Business Opportunities 2025-2032 | Curium Pharma, …
The Latest study titled Nuclear Pharmacy Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the report…
Actinium Pharmaceuticals (ATNM) Garners Attention with Clinical Successes and St …
Actinium's Chief Medical Officer, said, "In addition to demonstrating unprecedented 100% access to BMT in Iomab-B treated patients with active r/r AML and achieving the primary endpoint of dCR with high statistical significance, we are excited by the compelling outcomes in patients with a TP53 mutation in the SIERRA trial. We look forward to returning to EBMT and once again highlighting the positive results from the Phase 3 SIERRA trial…
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma A …
Biotech Stocks Taking Centerstage
As the pharmaceutical industry ventures deeper into the era of precision medicine, radiopharmaceuticals, particularly those involving alpha emitters like Actinium-225 (Ac-225), are gaining prominence for their targeted approach to cancer treatment. Amid this innovative surge, Actinium Pharmaceuticals (NYSE:ATNM) emerges not just as a company with a promising pipeline but as a beacon of cutting-edge manufacturing capabilities that could very well position it as a prime buyout candidate…
2030 Projections: Radiopharmaceutical Synthesizers Market to Deliver Dynamic Pro …
The Radiopharmaceutical Synthesizers Market Research Report 2023-2030 provides in-depth information on market trends, market capacity, industry size, growth factors, share, innovations, competitive environment, business problems, and more. This report's historical data confirms demand growth on a global, national, and regional scale. The studies on the global industry cover everything from comprehensive research to market size and forecasting to dynamics, growth factors, prospects, and hazards, as well as vendor knowledge. The…
Automated Radiosynthesis Modules Market Strategic Assessment & SWOT Analysis 202 …
An Informative report titled as Global Automated Radiosynthesis Modules Market has recently been published by Report Consultant to its online repository. This statistical data offers an in-depth analysis by considering several segments, such as type, size, technology and applications. Different exploratory techniques such as, qualitative and quantitative analysis have been used to give data accurately. For better understanding of the customers, it uses effective graphical presentation techniques, such as graphs,…
Cyclotron Market Growth Opportunities Analysis Report | GE Healthcare, Siemens H …
Cyclotron Market: Introduction
According to the report, the global cyclotron market was valued at US$ 215.5 Mn in 2019. It is projected to expand at a CAGR of ~3% from 2020 to 2030. Expansion activities of key radiopharma players; applications in clinical trials; increase in the geriatric population; pipeline assessment of new drugs; and disease indication mortality are major factors driving the cyclotron market. The shutdown of a few nuclear reactors has led to the…
